Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Schnedl, C; Fahrleitner-Pammer, A; Pietschmann, P; Amrein, K.
FGF23 in Acute and Chronic Illness.
Dis Markers. 2015; 2015(12):358086-358086 Doi: 10.1155/2015/358086 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Leading authors Med Uni Graz: Amrein Karin; Schnedl Christian
Co-authors Med Uni Graz: Fahrleitner-Pammer Astrid
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: FGF23 is a bone-derived phosphaturic hormone that may become a useful biomarker for the identification of high-risk patients in chronic but also acute disease. It rises early in chronic kidney disease and is strongly and independently associated with excess morbidity and mortality. Emerging data suggest that FGF23 is also elevated in different scenarios of acute illness. In this review, we give an overview on the role of this interesting disease marker and potential and proven interventional strategies and discuss a blueprint for future research.
Find related publications in this database (using NLM MeSH Indexing): Animals -; Biomarkers - blood; Biomarkers - metabolism; Cardiovascular Diseases - blood; Fibroblast Growth Factors - blood; Fibroblast Growth Factors - metabolism; Humans -; Renal Insufficiency, Chronic - blood; Sepsis - blood